References
- Ritz J., Schlossman S. F. Utilization of monoclonal antibodies in the treatment of leukemia and lymphoma. Blood 1982; 59: 1–11
- Levy R., Miller R. A. Biological and clinical implications of lymphocyte hybridomas: tumour therapy with monoclonal antibodies. Annu. Rev. Med. 1983; 34: 107–127
- Foon K. A. Biological response modifiers: the new immunotherapy. Cancer Res. 1989; 49: 1621–1639
- Dillman R. O. Monoclonal antibodies for treating cancer. Ann. Int. Med. 1989; 111: 592–603
- Grossbard M. L., Press O. W., Appelbaum F. R., Bernstein I. D., Nadler L. M. Monoclonal antibody-based therapies of leukemia and lymphoma. Blood 1992; 80: 863–878
- Meeker T. C, Lowder J., Maloney D. G., Miller R., Thielemans K., Warnke R., Levy R. A clinical trial of anti-idiotype therapy for B-cell malignancy. Blood 1985; 65: 1349–1363
- Dyer M. J. S., Hale G., Marcus R., Waldmann H. Remission induction in patients with lymphoid malignancies using unconjugated CAMPATH-1 monoclonal antibodies. Leukemia and Lymphoma 1990; 2: 179–193
- Henniker A. J., Bradstock K. F., Grimsley P., Atkinson K. A novel human leucocyte surface membrane antigen defined by murine monoclonal antibody. Tissue Antigens 1990; 35: 25–32
- Henniker A. J., Bradstock K. F., Grimsley P., Atkinson M. K. A novel non-lineage antigen on human leucocytes: characterization with two CD48 monoclonal antibodies. Disease Markers 1990; 8: 179–190
- Henniker A. J., Bradstock K. F. Purification of two murine monoclonal antibodies of the IgM class by hydroxylapatite chromatography and gel filtration. Biomed. Chromatog. 1993; 7: 121–125
- Ritz J., Pesando J. M., Sallan S. E., Clawell L. A., Notis-McConarty J., Rosenthal P., Schlossmann S. F. Serotherapy of acute lymphoblastic leukemia with monoclonal antibody. Blood 1981; 58: 141–152
- Foon K. A., Schroff R. W., Bunn P. A., Mayer D., Abrams P. G., Fer M., Ochs J., Bottino G. C, Sherwin S. A., Carlo D. J., Herberman R. B., Oldham R. K. Effects of monoclonal antibody therapy in patients with chronic lymphocytic leukemia. Blood 1984; 64: 1085–1093
- Dillman R. O., Beauregard J., Shawler D. L., Halpern S. E., Markman M., Ryan K. P., Baird S. M., Clutter M. Continuous infusion of T101 monoclonal antibody in chronic lymphocytic leukemia and cutaneous T-cell lymphoma. J. Biol. Resp. Modif. 1986; 5: 394
- Nadler L. M., Stashenko P., Hardy R., Kaplan W. D., Button L. N., Kufe D. W., Amman K. H., Schlossman S. F. Serotherapy of a patient with a monoclonal antibody directed against a human lymphoma-associated antigen. Cancer Res. 1980; 40: 3147–3154
- Dyer M. J. S., Hale G., Hayhoe F. G. J., Waldmann H. Effects of CAMPATH-1 antibodies in vivo in patients with lymphoid malignancies: influence of antibody isotype. Blood 1989; 73: 1431–1439
- Hale G., Dyer M. J. S., Clark M. R., Phillips J. M., Marcus R., Riechmann L., Winter G., Waldmann H. Remission induction in non-Hodgkin lymphoma with reshaped human monoclonal antibody CAMPATH-1 H. Lancet 1988; 2: 1394–1399